ATE115128T1 - 3-arylindol- und 3-arylindazolderivate. - Google Patents

3-arylindol- und 3-arylindazolderivate.

Info

Publication number: ATE115128T1
Authority: AT; Austria
Prior art keywords: alkyl; hydrogen; group; trifluoromethyl; cycloalkyl
Prior art date: 1990-07-30

Application number

AT91610058T

Other languages

English (en)

Inventor

Jens Kristian Perregaard

Kim Andersen

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-07-30

Filing date

1991-07-22

Publication date

1994-12-15

1991-07-22 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

1994-12-15 Application granted granted Critical

1994-12-15 Publication of ATE115128T1 publication Critical patent/ATE115128T1/de

Links

125000000217 alkyl group Chemical group 0.000 abstract 4
229910052739 hydrogen Inorganic materials 0.000 abstract 4
150000002431 hydrogen Chemical class 0.000 abstract 4
239000001257 hydrogen Substances 0.000 abstract 4
229910052760 oxygen Inorganic materials 0.000 abstract 3
229910052717 sulfur Inorganic materials 0.000 abstract 3
125000003342 alkenyl group Chemical group 0.000 abstract 2
125000000753 cycloalkyl group Chemical group 0.000 abstract 2
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical class 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
125000002030 1,2-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([*:2])C([H])=C1[H] 0.000 abstract 1
208000019901 Anxiety disease Diseases 0.000 abstract 1
208000019695 Migraine disease Diseases 0.000 abstract 1
208000018737 Parkinson disease Diseases 0.000 abstract 1
208000027089 Parkinsonian disease Diseases 0.000 abstract 1
206010034010 Parkinsonism Diseases 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000003282 alkyl amino group Chemical group 0.000 abstract 1
125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
125000004414 alkyl thio group Chemical group 0.000 abstract 1
230000036506 anxiety Effects 0.000 abstract 1
210000004556 brain Anatomy 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
125000004981 cycloalkylmethyl group Chemical group 0.000 abstract 1
125000004663 dialkyl amino group Chemical group 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
206010027599 migraine Diseases 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
201000000980 schizophrenia Diseases 0.000 abstract 1
239000003215 serotonin 5-HT2 receptor antagonist Substances 0.000 abstract 1
208000019116 sleep disease Diseases 0.000 abstract 1
208000022925 sleep disturbance Diseases 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1
125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)

AT91610058T 1990-07-30 1991-07-22 3-arylindol- und 3-arylindazolderivate. ATE115128T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK181190A DK181190D0 (da)	1990-07-30	1990-07-30	3-aryl-indol- eller 3-aryl-indazolderivater
SG19995A SG19995G (en)	1990-07-30	1995-02-07	Novel 3-arylindole and 3-arylindazole derivatives

Publications (1)

Publication Number	Publication Date
ATE115128T1 true ATE115128T1 (de)	1994-12-15

Family

ID=26066139

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91610058T ATE115128T1 (de)	1990-07-30	1991-07-22	3-arylindol- und 3-arylindazolderivate.

Country Status (20)

Country	Link
US (1)	US5393761A (de)
EP (1)	EP0470039B1 (de)
JP (1)	JP3165181B2 (de)
KR (1)	KR100233955B1 (de)
AT (1)	ATE115128T1 (de)
AU (1)	AU646679B2 (de)
CA (1)	CA2048027C (de)
DE (1)	DE69105659T2 (de)
DK (2)	DK181190D0 (de)
ES (1)	ES2064974T3 (de)
FI (1)	FI99111C (de)
GR (1)	GR3015274T3 (de)
HK (1)	HK51495A (de)
IE (1)	IE65673B1 (de)
IL (1)	IL98829A (de)
NO (1)	NO178192C (de)
NZ (1)	NZ238956A (de)
PT (1)	PT98483B (de)
SG (1)	SG19995G (de)
ZA (1)	ZA915805B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5643784A (en) *	1990-12-04	1997-07-01	H, Lundbeck A/S	Indan derivatives
NZ243065A (en) *	1991-06-13	1995-07-26	Lundbeck & Co As H	Piperidine derivatives and pharmaceutical compositions
DK8492D0 (da) *	1992-01-23	1992-01-23	Lundbeck & Co As H	Behandling af psykoser
US5264576A (en) *	1992-10-22	1993-11-23	Hoechst-Roussel Pharmaceuticals Incorporated	Pyrazolo[4,3-c]pyridines which are intermediates
TW421649B (en) *	1995-01-31	2001-02-11	Janssen Pharmaceutica Nv	4-(1H-indol-1yl)-1-piperidinyl derivatives
GB9523462D0 (en) *	1995-11-16	1996-01-17	Merck Sharp & Dohme	Therapeutic agents
FR2744452B1 (fr) *	1996-02-06	1998-03-06	Cird Galderma	Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
DE19642255A1 (de)	1996-10-14	1998-04-16	Bayer Ag	Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten
TWI242011B (en)	1997-03-31	2005-10-21	Eisai Co Ltd	1,4-substituted cyclic amine derivatives
FR2788772B1 (fr) *	1999-01-26	2001-03-02	Adir	Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2001092223A1 (en) *	2000-05-26	2001-12-06	Ciba Specialty Chemicals Holding Inc.	Process for the preparation of indole derivatives and intermediates of the process
IL157363A0 (en) *	2001-02-16	2004-02-19	Aventis Pharma Inc	Novel heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
GB0117950D0 (en) *	2001-02-16	2001-09-19	Aventis Pharma Inc	Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
EP1539742B1 (de)	2002-06-24	2006-11-08	Schering Corporation	Als histamin-h3-antagonisten geeignete indolderivate
TW200409759A (en)	2002-09-25	2004-06-16	Wyeth Corp	Substituted 4-(indazol-3-yl)phenols
GB0306604D0 (en) *	2003-03-21	2003-04-30	Curidium Ltd	Second medical use
CA2546493A1 (en)	2003-11-19	2005-06-09	Signal Pharmaceuticals, Llc	Indazole compounds and methods of use thereof as protein kinase inhibitors
DE102006043443A1 (de) *	2006-09-15	2008-03-27	Bayer Healthcare Ag	Neue aza-bicyclische Verbindungen und ihre Verwendung
DE102010021637A1 (de)	2010-05-26	2011-12-01	Bayer Schering Pharma Aktiengesellschaft	Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung
WO2014102588A2 (en) *	2012-12-27	2014-07-03	Purdue Pharma L.P.	Indole and indoline-type piperidine compounds and uses thereof
EP3760629A1 (de)	2013-02-21	2021-01-06	Adverio Pharma GmbH	Formen von {4,6-diamino-2-[1-(2-fluorbenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methylcarbamat

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2354766A1 (fr) *	1976-06-17	1978-01-13	Labaz	Derives n-aminoalkyles d'indole et procedes pour les preparer
FR2421900A1 (fr) *	1977-03-17	1979-11-02	Sauba Lab	Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
HU198036B (en) *	1983-08-22	1989-07-28	Hoechst Roussel Pharma	Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them
DK704488D0 (da) *	1988-12-19	1988-12-19	Novo Industri As	Nye n-substituerede azaheterocykliske carboxylsyrer
IE58370B1 (en) *	1985-04-10	1993-09-08	Lundbeck & Co As H	Indole derivatives

1990
- 1990-07-30 DK DK181190A patent/DK181190D0/da not_active Application Discontinuation
1991
- 1991-07-09 IE IE240391A patent/IE65673B1/en not_active IP Right Cessation
- 1991-07-12 NO NO912739A patent/NO178192C/no not_active IP Right Cessation
- 1991-07-12 NZ NZ238956A patent/NZ238956A/xx unknown
- 1991-07-15 IL IL98829A patent/IL98829A/en not_active IP Right Cessation
- 1991-07-22 EP EP91610058A patent/EP0470039B1/de not_active Expired - Lifetime
- 1991-07-22 DE DE69105659T patent/DE69105659T2/de not_active Expired - Fee Related
- 1991-07-22 AT AT91610058T patent/ATE115128T1/de not_active IP Right Cessation
- 1991-07-22 ES ES91610058T patent/ES2064974T3/es not_active Expired - Lifetime
- 1991-07-22 DK DK91610058.9T patent/DK0470039T3/da active
- 1991-07-24 ZA ZA915805A patent/ZA915805B/xx unknown
- 1991-07-27 KR KR1019910012971A patent/KR100233955B1/ko not_active Expired - Fee Related
- 1991-07-29 CA CA002048027A patent/CA2048027C/en not_active Expired - Fee Related
- 1991-07-29 PT PT98483A patent/PT98483B/pt not_active IP Right Cessation
- 1991-07-29 JP JP18892391A patent/JP3165181B2/ja not_active Expired - Fee Related
- 1991-07-29 FI FI913613A patent/FI99111C/fi active
- 1991-07-29 AU AU81411/91A patent/AU646679B2/en not_active Ceased
1993
- 1993-10-04 US US08/131,438 patent/US5393761A/en not_active Expired - Fee Related
1995
- 1995-02-07 SG SG19995A patent/SG19995G/en unknown
- 1995-03-03 GR GR940404079T patent/GR3015274T3/el unknown
- 1995-04-06 HK HK51495A patent/HK51495A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU646679B2 (en)	1994-03-03
NO178192B (no)	1995-10-30
ES2064974T3 (es)	1995-02-01
NO912739L (no)	1992-01-31
DK0470039T3 (da)	1995-05-15
AU8141191A (en)	1992-02-06
IL98829A (en)	1996-06-18
GR3015274T3 (en)	1995-06-30
FI99111C (fi)	1997-10-10
DK181190D0 (da)	1990-07-30
KR100233955B1 (ko)	2000-02-01
DE69105659D1 (de)	1995-01-19
KR920002588A (ko)	1992-02-28
PT98483B (pt)	1997-09-30
IE65673B1 (en)	1995-11-15
NZ238956A (en)	1993-12-23
FI99111B (fi)	1997-06-30
SG19995G (en)	1995-08-18
EP0470039A3 (en)	1992-05-27
NO178192C (no)	1996-02-07
NO912739D0 (no)	1991-07-12
JPH04368367A (ja)	1992-12-21
IL98829A0 (en)	1992-07-15
US5393761A (en)	1995-02-28
HK51495A (en)	1995-04-13
FI913613A7 (fi)	1992-01-31
DE69105659T2 (de)	1995-04-27
EP0470039A2 (de)	1992-02-05
CA2048027A1 (en)	1992-01-31
EP0470039B1 (de)	1994-12-07
IE912403A1 (en)	1992-02-12
JP3165181B2 (ja)	2001-05-14
ZA915805B (en)	1992-04-29
PT98483A (pt)	1992-05-29
CA2048027C (en)	2001-10-30
FI913613A0 (fi)	1991-07-29

Legal Events

Date	Code	Title	Description
1995-05-15	UEP	Publication of translation of european patent specification
2004-04-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE115128T1 (de)	1994-12-15	3-arylindol- und 3-arylindazolderivate.
DE69120100D1 (de)	1996-07-18	Annelierte Thiophen-Derivate, ihre Herstellung und Verwendung
NO178191C (no)	1996-02-07	Analogifremgangsmåte ved fremstilling av terapeutisk aktive indolderivater
DE69109132D1 (de)	1995-05-24	Indanderivate.
ES2088903T3 (es)	1996-10-01	Nuevos inhibidores de la s-adenosilmetionina descarboxilasa.
DE69406763D1 (de)	1997-12-18	Pyridazinon Derivate, Herstellungsverfahren und Verwendung
ATE198750T1 (de)	2001-02-15	Isatinoxim-derivate, ihre herstellung und verwendung
ATE108444T1 (de)	1994-07-15	3-isoxazolonderivate, ihre herstellung und ihre anwendung in der therapeutik.